Atopic eczema/dermatitis syndrome and Malassezia

International Archives of Allergy and Immunology

Volumn 127, Issue 3, 2002, Pages 161-169

  Scheynius, Annika ^a,c   Johansson, Catharina ^a   Buentke, Eva ^a   Zargari, Arezou ^b   Tengvall Linder, Maria ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atopic eczema dermatitis syndrome; Atopy patch test; Malassezia; Recombinant allergens

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E;

ATOPIC DERMATITIS; ATOPIC ECZEMA DERMATITIS SYNDROME; DIAGNOSTIC PROCEDURE; FUNGAL GENE; FUNGUS ISOLATION; GENE IDENTIFICATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALASSEZIA; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; PATCH TEST; PATHOGENESIS; PITYROSPORUM; PRICK TEST; PRIORITY JOURNAL; REVIEW; SKIN INFLAMMATION; SYNDROME DELINEATION;

ALLERGENS; ANTIGENS, FUNGAL; DERMATITIS, ATOPIC; HUMANS; IMMUNOGLOBULIN E; MALASSEZIA; RECOMBINANT PROTEINS; SKIN TESTS; SYNDROME;

EID: 0036241867     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053860     Document Type: Review

References (105)

1. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC
2. Atopy in children of families with an anthroposophic lifestyle
3. Atopic dermatitis: A genetic-epidemiologic study in a population-based twin sample
4. The causes of the increasing prevalence of allergy: Is atopy a microbial deprivation disorder?
5. Immunoglobulins in atopic dermatitis with special reference to IgE
6. Environmental and other major provocation factors in atopic dermatitis
7. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force
8. Pityrosporum species as a cause of allergy and infection
9. Treatment of dermatitis of the head and neck with ketoconazole in patients with type I sensitivity to Pityrosporum orbiculare
10. Ketoconazole in atopic dermatitis: Therapeutic response is correlated with decrease in serum IgE
11. Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts
12. Systemic ketoconazole for yeast allergic patients with atopic dermatitis
13. IgE antibodies to Pityrosporum orbiculare in children with atopic diseases
14. Immune reactions to Pityrosporum ovale in adult patients with atopic and seborrheic dermatitis
15. Contact sensitivity to Pityrosporum ovale in patients with atopic dermatitis
16. IgE antibodies to Pityrosporum ovale in atopic dermatitis
17. Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: A comparison with asthmatic and nonasthmatic control subjects
18. Head and neck dermatitis: The role of Malassezia furfur, topical steroid use and environmental factors in its causation
19. IgE antibodies to Malassezia furfur, M. sympodialis and Pityrosporum orbiculare in patients with atopic dermatitis, seborrheic eczema or pityriasis versicolor, and identification of respective allergens
20. Positive atopy patch test reactions to Pityrosporum orbicularein atopic dermatitis patients
21. The diversity of Pityrosporum (Malassezia) yeasts in vivo and in vitro
22. Quantitative variations in distribution of Pityrosporum orbiculare on clinically normal skin
23. Age incidence of Pityrosporum orbiculareon human skin
24. Electron microscopy of Malassezia furfur in tinea versicolor
25. Fine structural investigation of Malassezia furfur. II. The envelope of the yeast cells
26. The genus Malassezia with description of four new species
27. Pilzbildung in der Pityriasis versicolor
28. Tinea versicolor and Pityrosporum orbiculare: Mycological investigations, experimental infections and epidemiological surveys
29. Pityrosporum folliculitis. Report of seven cases and review of the Pityrosporum organism relative to cutaneous disease
30. Malassezia globosa as the causative agent of pityriasis versicolor
31. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects
32. Epidemiology of Malassezia yeasts associated with pityriasis versicolor in Ontario, Canada
33. Molecular analysis of Malassezia microflora on the skin of atopic dermatitis patients and healthy subjects
34. The yeast Malassezia on the skin of healthy individuals and patients with atopic dermatitis
35. Förekomst av jästsvampen Malassezia vid atopisk dermatit och seborroisk dermatit
36. IgE-binding components in Pityrosporum orbiculare identified by an immunoblotting technique
37. Identification of allergen components of the opportunistic yeast Pityrosporum orbiculare by monoclonal antibodies
38. Allergen cross-reactivity between Pityrosporum orbiculare and Candida albicans
39. IgE antibodies to protein and mannan antigens of Pityrosporum ovale in atopic dermatitis patients
40. Influence of culture period on the allergenic composition of Pityrosporum orbiculare extracts
41. Serum IgE reactivity to Malassezia furfur extract and recombinant M. furfur allergens in patients with atopic dermatitis
42. Positive atopy patch test reaction to Malassezia furfur in atopic dermatitis correlates with a Th2 like PBMC response
43. Malassezia furfur invasiveness in a keratinocyte cell line (HaCat): Effects on cytoskeleton and on adhesion molecule and cytokine expression
44. Cell surface expression of two major yeast allergens in the Pityrosporum genus
45. Proliferating dendritic cell progenitors in human blood
46. Uptake of the yeast Malassezia furfur and its allergenic components by human immature CD1a+ dendritic cells
47. The allergenic yeast Malassezia furfur induces maturation of human dendritic cells
48. Allergens of Pityrosporum ovale and Candida albicans. II. Physicochemical characterization
49. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells
50. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils
51. IL-18 induction of IgE: Dependence on CD4+ T cells, IL-4 and STAT6
52. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis
53. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells
54. Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE
55. The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation
56. IgE on Langerhans cells: New insights into the pathogenesis of atopic dermatitis
57. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis
58. Occurrence of IgE-bearing epidermal Langerhans cells in atopic eczema: A study of the time course of the lesions and with regard to the IgE serum level
59. IgE-binding molecules on human Langerhans cells
60. Evaluation of the atopy patch test and the cutaneous late-phase reaction as relevant models for the study of allergic inflammation in patients with atopic eczema
61. Atopy patch test reactions are associated with T lymphocyte-mediated allergen-specific immune responses in atopic dermatitis
62. Clinical and immunologic variables in skin of patients with atopic eczema and either positive or negative atopy patch test reactions
63. Detection of Pityrosporum orbiculare reactive T cells from skin and blood in atopic dermatitis and characterization of their cytokine profiles
64. Pityrosporum orbiculare-reactive T-cell lines in atopic dermatitis patients and healthy individuals
65. Pityrosporum and Candida specific and non-specific humoral, cellular and cytokine responses in atopic dermatitis patients
66. Pityrosporum ovale extracts increase interleukin-4, interleukin-10 and IgE synthesis in patients with atopic eczema
67. Atopic dermatitis: New insights and opportunities for therapeutic intervention
68. Active participation of eosinophils in patch test reactions to inhalant allergens in patients with atopic dermatitis
69. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis
70. Atopic dermatitis - The skin manifestation of atopy
71. High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin
72. Lesional expression of interferon-gamma in atopic eczema
73. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis
74. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis
75. Pityrosporum orbiculare - A pathogenic factor in atopic dermatitis of the face, scalp and neck?
76. Pityrosporum ovale and atopic dermatitis in children and young adults
77. Occurrence and clinical features of sensitization to Pityrosporum orbiculare and other allergens in children with atopic dermatitis
78. Antigenic components of Malassezia species for immunoglobulin E antibodies in sera of patients with atopic dermatitis
79. Antibodies to Pityrosporum orbiculare in patients with tinea versicolor and controls of various ages
80. Basophils in allergen-induced patch test sites in atopic dermatitis
81. Aeroallergen contact dermatitis
82. Airborne and dietary allergens in atopic eczema: A comprehensive review of diagnostic tests
83. Demonstration of clinically relevant sensitization of house dust mite allergen in prick and RAST negative atopic dermatitis patients with the atopy patch test
84. Epidemiology, clinical features, and immunology of the 'intrinsic' (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis)
85. Microarrayed allergen molecules: Diagnostic gatekeepers for allergy treatment
86. Exfoliative dermatitis in the Indian rhinoceros (Rhinoceros unicornis), with description of a new yeast species, Pityrosporum pachydermatis
87. Lipophilic yeast-like organisms associated with tinea versicolor
88. Polymorphism of Pityrosporum ovale (Bizzozero) Castellani and Chalmers in vivo and in vitro
89. Antigenic similarities and differences in genus Pityrosporum
90. A reevaluation of the genus Malassezia by means of genome comparison
91. Differentiation of three serovars of Malassezia furfur
92. A new species of Malassezia
93. The diversity of Malassezia yeasts confirmed by rRNA sequence and nuclear DNA comparisons
94. The complete cDNA sequence and expression of the first major allergenic protein of Malassezia furfur, Mal f 1
95. Identification and cloning of two novel allergens from the lipophilic yeast, Malassezia furfur
96. Two-dimensional electrophoresis of Malassezia allergens for atopic dermatitis and isolation of Mal f 4 homologs with mitochondrial malate dehydrogenase
97. Selective cloning of allergens from the skin colonizing yeast Malassezia furfur by phage surface display technology
98. Cloning, characterization and expression of complete coding sequences of three IgE binding Malassezia furfur allergens, Mal f 7, Mal f 8 and Mal f 9